Clinical trials
TB clinical trials
Below are recruiting tb clinical trials, each written for real people, not researchers. We’re tracking 67 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06482645Recruiting
Testing a new biopsy method for prostate cancer diagnosis
This study is testing a new approach to prostate biopsy that takes samples from around a suspicious area seen on MRI. It aims to see if this method can better detect prostate cancer compared to standard biopsy.
Beijing, Beijing MunicipalityAges 45–85 - NCT06221488Recruiting
TB testing for health workers at risk
This study tests health workers for tuberculosis (TB) infection to better understand who is at risk. It may help find ways to protect health workers from TB.
Cape TownAges 18–100 - NCT05671718Recruiting
Nurse vs doctor treatment for drug-resistant tuberculosis
This trial compares a nurse-led plan versus a physician-led plan for treating new drug-resistant TB patients using an outpatient clinic approach. It may help by showing which care style works best and is safest for patients starting treatment close to home.
Pietermaritzburg, KwaZulu-NatalAges 18 years+ - NCT05426720Recruiting
Looking for TB lung damage risk factors and blood markers
This study looks at what increases the risk of long-term lung damage after active pulmonary tuberculosis (TB). It also tests whether certain blood or other markers can predict who is more likely to have lung problems later.
BeijingAges 25–60 - NCT07811518RecruitingPhase 4
Tracking tuberculosis infection in new college students
This study follows new college students with a strong reaction to a tuberculosis skin test to see if they develop the disease, and compares them to students without a strong reaction. It tests whether monitoring this group more closely can help catch tuberculosis early.
Nantong, JiangsuAges 14–24 - NCT06485895Recruiting
Testing a new TB blood test for diagnosis
This study is testing a new blood test (IGRA) to see if it can help doctors diagnose active and latent (hidden) tuberculosis. If you are already being treated for TB and have had an IGRA blood test, you may be able to join.
MarseilleAges 18 years+ - NCT06701110RecruitingPhase 1
Study of sudapyridine in healthy Chinese men
This trial tests how Sudapyridine (WX-081) moves through the body in healthy Chinese men. It helps researchers understand the drug's effects and safety before moving to later studies.
Suzhou, JiangsuAges 18–45 - NCT06702774Recruiting
TB control study for high-risk groups in Guangxi
This study tests new ways to control the spread of tuberculosis (TB) in high-risk areas of Guangxi, China. It focuses on older adults and people with conditions that make them more likely to get TB.
Nanning, GuangxiAges 15 years+ - NCT07516223Recruiting
MRI-guided prostate biopsy to reduce unnecessary tissue sampling
This study tests whether using MRI imaging to guide prostate biopsies can help doctors sample only suspicious areas instead of taking many samples throughout the prostate. It may reduce discomfort and complications while still finding prostate cancer if present.
ShanghaiAges 45 years+ - NCT06764576Recruiting
Study for people with suspected tuberculosis or related infections
This trial is looking for adults who might have tuberculosis, a related infection called non-tubercular mycobacteriosis, or a hidden (latent) tuberculosis infection. You will provide a sample for testing, and the study will help doctors understand and manage these infections better.
BolognaAges 18 years+ - NCT05655702Recruiting
Drug use and infections study for tuberculosis control in Vietnam
This study looks at how injecting drug use is linked with infections, including tuberculosis, and aims to improve TB control. You may be asked to share information and provide tests related to recent drug use and injection sites.
HaiphongAges 18 years+ - NCT07303699RecruitingPhase 2
Atorvastatin with TB meds: a drug study for TB patients
This study tests if adding the cholesterol drug atorvastatin to standard TB treatment can help clear the infection faster. It looks at how the body processes the drugs and how well they work together.
Zaria, Kaduna StateAges 12 years+ - NCT06902194Recruiting
Kids' immune response to respiratory infections study
This study looks at how South African children's immune systems respond to acute respiratory infections. It may help find better ways to treat or prevent these infections.
Cape Town, Western CapeAges Up to 13 years - NCT06033807Recruiting
Screening for hidden TB in school contacts
This study tests a program to find hidden (latent) tuberculosis infections in students who have been close to someone with active TB. It helps identify who might need treatment to prevent them from getting sick later.
Zunyi, GuiyangAges 13 years+ - NCT07234929Recruiting
Chat reminders for follow-up after abnormal chest x-rays
This trial tests if getting reminders through the Zalo chat app helps people complete follow-up tests after an abnormal chest x-ray. It aims to catch lung cancer early in people at higher risk.
Ho Chi Minh City, Ho Chi Minh CityAges 40–62 - NCT06946784Recruiting
Long-term lung health after tuberculosis in Korea
This study looks at how tuberculosis affects your lungs and daily life over the long term. It helps researchers understand the lasting impacts so they can improve care for people who have had TB.
SeoulAges 19 years+ - NCT07178860Recruiting
Lung health after TB treatment study
This study looks at your lung health and overall wellbeing after finishing treatment for tuberculosis (TB). It aims to understand how TB affects breathing and quality of life, so doctors can better support recovery.
LiverpoolAges 18 years+ - NCT07152639RecruitingPhase 3
New skin test for tuberculosis in people 3 and older
This trial tests a new skin test (EEC) to see if it can accurately detect tuberculosis infection in people aged 3 and older. It compares the test's results in healthy people, people with TB, and people with other lung diseases to check how well it works.
Beijing, Beijing MunicipalityAges 3 years+ - NCT07125274Recruiting
New Sputum-Free Test for TB Diagnosis
This study is testing a new way to diagnose tuberculosis (TB) without needing sputum (phlegm) samples. It aims to find a simpler, faster method for people with possible TB or other lung infections.
HamburgAges 18 years+ - NCT07117370Recruiting
Coach Mpilo app for men with TB and HIV
This study tests a coaching app (Coach Mpilo) to help men in South Africa who are starting or restarting TB treatment, and for those who also have HIV but are not yet on HIV medication. The goal is to see if the app is helpful and usable.
East LondonAges 18 years+ - NCT07097961Recruiting
Rehab program for kids with lung damage after TB
This study tests a rehab program for children aged 6-17 who have lung damage from a past tuberculosis (TB) infection. The program uses mild-to-moderate physical activity to help improve their breathing and daily life.
KampalaAges 6–17 - NCT07074470Recruiting
New drug combo for relapsed brain lymphoma
This trial tests a new combination of drugs (teniposide, a PD-1 checkpoint inhibitor, and selinexor) for people with relapsed or refractory primary central nervous system lymphoma. It aims to see if this three-drug approach can shrink tumors or slow the disease when previous treatments haven't worked.
Suzhou, JiangsuAges 18–75 - NCT07024836Recruiting
Precision biomarker-guided management of TB contacts
This study looks at how to best manage latent tuberculosis (TB) infection using a test that finds people at risk. It aims to help doctors and patients make better decisions together.
LondonAges 18 years+ - NCT07018076Recruiting
TB treatment study for people who just finished therapy
This study looks for people who have recently completed standard treatment for drug-sensitive TB. Researchers want to check if certain tests can predict long-term health outcomes after treatment.
KampalaAges 12 years+
Hear when a new TB trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for tb?
- Yes. Clin2 currently lists 67 recruiting tb studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a tb trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a tb trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.